| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.parmaxpharma.com | |
| Market Cap | 11.16 Cr. | |
| Enterprise Value(EV) | 16.64 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -11.03 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 40.73 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 1.20 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 24.80 | Calculated using Price: 29.82 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.37 Cr. | 3,741,300 Shares |
| FaceValue | 10 | |
| About Parmax Pharma Ltd. | ||
| Parmax Pharma was incorporated on November 02, 1994. The certificate of commencement of business was received by the company on March 10, 1995.The IPO of the company was January 30, 1996 with 5100800 shares of Rs10/-each. The promoters were earlier in manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The company then discontinued its business activities for few years due to various reasons. The company also plans to extend its activity in formulation of Tablets, Capsules, Ointments, & Injectable. | ||
| 1 Day |
|
-8.89% |
| 1 Week |
|
-5.99% |
| 1 Month |
|
-6.73% |
| 3 Month |
|
-12.50% |
| 6 Month |
|
-6.94% |
| 1 Year |
|
-13.68% |
| 2 Year |
|
-31.42% |
| 5 Year |
|
+65.90% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.7 | -0.12 | -0.28 | 0.02 | 3.71 | 18.19 | 22.55 | 3.38 | -2.26 | |
| Return on Capital Employed (%) | 0.88 | 0.28 | 0.18 | 0.81 | 1.96 | 10.19 | 16.25 | 6.62 | 3.93 | |
| Return on Assets (%) | 0.45 | -0.08 | -0.12 | 0 | 0.43 | 2.11 | 3.45 | 0.7 | -0.58 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 3 | |
| Non Curr. Liab. | 1 | 0 | 1 | 2 | 5 | 5 | 6 | 5 | 5 | 6 | |
| Curr. Liab. | 0 | 0 | 2 | 10 | 10 | 11 | 11 | 7 | 7 | 7 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 5 | 5 | 8 | 17 | 20 | 21 | 23 | 18 | 18 | 15 | |
| Non Curr. Assets | 3 | 3 | 3 | 6 | 9 | 10 | 11 | 11 | 10 | 10 | |
| Curr. Assets | 2 | 2 | 4 | 9 | 9 | 9 | 10 | 7 | 8 | 6 | |
| Misc. Exp. not W/O | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 0 | ||
| Total Assets | 5 | 5 | 8 | 17 | 20 | 21 | 23 | 18 | 18 | 15 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 12 | 12 | 21 | 26 | 18 | 15 | 13 | ||||
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 0 | 0 | 0 | 12 | 12 | 21 | 26 | 18 | 15 | 13 | |
| Total Expenditure | 0 | 0 | 0 | -11 | -11 | -19 | -23 | -16 | -13 | -15 | |
| PBIDT | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 3 | 2 | -2 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | -1 | ||||
| Depreciation | -1 | -1 | -1 | -2 | -2 | -2 | -2 | ||||
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -4 | |||
| Adjusted EPS | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | -11 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -1 | 4 | 1 | 3 | 4 | 1 | 0 | ||
| Cash Fr. Inv. | 0 | -4 | -3 | -2 | -3 | -2 | -1 | ||||
| Cash Fr. Finan. | 0 | 0 | 1 | 1 | 3 | 0 | 0 | -1 | 0 | ||
| Net Change | 0 | 0 | 0 | 1 | 1 | 0 | 1 | -2 | -1 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 1 | 0 |
|
Fri, 12 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 for the year ended on 31st March 2024 |
|
Fri, 12 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 for the year ended on 31st March 2024 |
|
Sun, 07 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 certificate under regulation 74(5) SEBI (Depositories and Participants) regulations 2018 For the quarter ended on 31st March 2024. |
| Fri, 19 Apr 2024 |
High Delivery Percentage
|
Opening at High
|
Closing Below Previous Low
|
Opening at High for 2 Days
|
CCI Trending Down
|
